The HIV Prevention Trials Network develops and tests the safety and efficacy of primarily non-vaccine interventions designed to prevent the transmission of HIV.
Main Areas of Focus
- To discover and develop new and innovative research strategies to reduce the acquisition and transmission of HIV
The Executive Committee is made up of: Principal Investigators (PIs), International Lead Investigator, Past PI and Co-PI, SDMC PI & LC PI, LOC Director, Community Representative, two NIH Representatives, and two Site Representatives.
HPTN has 90 clinical research sites in more than 15 countries around the world.
HPTN holds an annual meeting as well as regular regional meetings.
Content last reviewed on